Lewy Body Dementia (LBD) patients are actively being recruited by Cognition Therapeutics, Inc. (NASDAQ:CGTX) and its clinical partners for the SHIMMER Phase 2 trial of their CT1812 oral drug therapy at 17
Gainers
Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Cantor Fitzgerald analyst Charles Duncan initiates coverage on Cognition Therapeutics (NASDAQ:CGTX) with a Overweight rating and announces Price Target of $12.
Gainers
Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.
Shares of biopharmaceutical company Alzamend Neuro Inc (NASDAQ: ALZN) are soaring Thursday afternoon after Cognition Therapeutics Inc (NASDAQ: CGTX) shares surged following the presentation of a proteomic